MEK1/2 inhibition enhances the radiosensitivity of cancer cells by downregulating survival and growth signals mediated by EGFR ligands

Eun Joo Chung, Mary Ellen Urick, Naamit Kurshan, William Shield, Hiroaki Asano, Paul D. Smith, Bradley S. Scroggins, Jeffrey Burkeen, Deborah E. Citrin

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)

Fingerprint

Dive into the research topics of 'MEK1/2 inhibition enhances the radiosensitivity of cancer cells by downregulating survival and growth signals mediated by EGFR ligands'. Together they form a unique fingerprint.

Medicine & Life Sciences